Revenue rose from KRW 566 billion in 2022 to KRW 753.1 billion in 2023, up 33.1% year on year, then grew 2.7% to KRW 773.3 billion in 2024 and 3.0% to KRW 796.1 billion in 2025, so the pace of growth slowed.
Revenue increased for three consecutive years from 2023 through 2025, and 2025 was the largest year in the 2022 to 2025 period. Operating profit climbed from KRW 13.3 billion in 2022 to KRW 44.1 billion in 2023, up 231.5%, eased 2.7% to KRW 42.9 billion in 2024, and recovered to KRW 48.6 billion in 2025, up 13.2%.
The operating margin moved from 2.3% in 2022 to 5.9% in 2023, then held at 5.6% in 2024 and 6.1% in 2025. In 2025, operating profit grew faster than revenue, so margin improvement drove most of the gain.
Controlling-shareholder net income was KRW 7.27 billion in 2022, KRW 20.8 billion in 2023 (up 186.6%), KRW 16.1 billion in 2024 (down 22.6%) and KRW 28.8 billion in 2025 (up 78.7%).
Net income including non-controlling interests was KRW 31.3 billion in 2025, and the gap from controlling-shareholder income reflects the non-controlling share. Operating cash flow was KRW 50.7 billion in 2025, above operating profit of KRW 48.6 billion, and the debt ratio fell from 133.2% in 2022 to 96.7% in 2025.
Quarterly, the third quarter of 2025 showed operating profit of KRW 15.8 billion and controlling-shareholder net income of KRW 11.2 billion, but the fourth quarter fell to operating profit of KRW 2.93 billion, down 81.4% from the prior quarter, and a controlling-shareholder net loss of KRW 1.38 billion.
The first quarter of 2026 returned to operating profit of KRW 6 billion and controlling-shareholder net income of KRW 3.72 billion, and the second quarter improved to operating profit of KRW 8.27 billion and net income of KRW 7.6 billion.
The third quarter of 2026 brought revenue of KRW 188.1 billion, down 5.2% year on year, operating profit of KRW 6.29 billion, down 60.2%, and a controlling-shareholder net loss of KRW 3.7 billion.
Whether the fourth-quarter 2025 and third-quarter 2026 losses reflect one-off items cannot be judged from the disclosed figures alone, so the cost lines in the periodic reports need to be read alongside them.